George Burslem is the recipient of an NIH R35 MIRA grant. Congratulations George!
George Burslem has been awarded a 2021-2022 Leukemia Research Foundation grant. Read more here, and congratulations George!
Dr. Elizabeth Heller was recently awarded a research grant award from the SynGAP Research Fund to support her lab’s work in epigenetic regulation of SynGAP1-related intellectual disability. With the SynGAP Research Fund’s award to support a postdoctoral fellow in the lab, Dr. Heller and her team will work to uncover druggable targets that could be used to develop a treatment for this rare genetic disorder. Congratulations, Dr. Heller, and many thanks to the team at the SynGAP Research Fund!
Learn more about the SynGAP Research Fund here.
Elizabeth Heller has received U18 funding from the NIH -NIDA Step Up for Substance Use Disorders (SUD): A Drug Target Initiative for Scientists Engaged in Fundamental Research, to study Nr4a1 as a target gene in cocaine use disorder. Congratulations!
Golnaz Vahedi has received U01 funding from the NIH to study transcriptomic and epigenomic of T cells in type 1 diabetes. Penn faculty John Wherry is a co-PI on this grant. Congratulations!
Golnaz Vahedi is the recipient of a Burroughs Wellcome Fund for 2020 Investigators in the Pathogenesis of Infectious Disease. Congratulations!
The Cremins lab receives funding through the Chan Zuckerberg Initiative for a Neurodegenerative Disease Pairs collaboration with Dr. Kristen Brennand. Congratulations!
Brian Capell has received an R01 from NIH for his proposal entitled “Epigenetic Enhancer Control in Maintaining Homeostasis and Preventing Carcinogenesis in the Epidermis.” Congratulations!
Liling Wan is the recipient of a New Investigator Award from the Leukemia Research Foundation. Read more here – congratulations!
Doris Wagner recently received an NSF Plant Genome Research Program Grant to examine whether there are different modes of Polycomb recruitment in plants with small as opposed to large genomes. Congratulations!